Key Takeaway
Systematic review of 29 studies found substantial evidence that blue-blocking glasses reduce sleep onset latency in patients with sleep disorders, jet lag, or shift work, with preliminary evidence for benefit in acute mania.
Summary
This systematic review examined the clinical evidence for wearing blue-blocking (amber) glasses in the evening as an intervention for sleep and mood disorders. The rationale is that blue light activates melanopsin-containing retinal ganglion cells involved in circadian rhythm regulation, and blocking this input in the evening may facilitate melatonin release and improve sleep.
The authors identified 29 experimental publications, including 16 randomized controlled trials (453 patients total), 5 uncontrolled trials, 1 case series, 1 case study, and 6 conference abstracts. Studies spanned populations with insomnia, delayed sleep phase disorder, jet lag, shift work, bipolar mania, ADHD, and depression.
For sleep disorders, the review found substantial evidence supporting blue-blocking glasses as an effective intervention for reducing sleep onset latency. Evidence was strongest for insomnia and delayed sleep phase disorder. For bipolar disorder, both available studies (one case study and one RCT) found substantial decreases in manic symptoms with blue-blocking glasses, representing preliminary but promising clinical evidence. Results for depression were heterogeneous and conflicting.
The authors concluded that blue-blocking glasses represent a viable, low-risk intervention for insomnia and delayed sleep phase disorders, and identified bipolar mania as a high-yield area for future research given the strong preliminary findings and biological plausibility.
Methods
- Systematic literature search across multiple databases
- Identified 29 experimental publications on blue-blocking glasses for sleep/mood
- Included 16 RCTs with 453 total patients
- Also included 5 uncontrolled trials, 1 case series, 1 case study, 6 conference abstracts
- Assessed evidence across sleep disorders, bipolar disorder, depression, ADHD, and jet lag
Key Results
- Substantial evidence for reducing sleep onset latency in insomnia and delayed sleep phase disorder
- Both bipolar mania studies showed substantial symptom decreases with blue-blocking glasses
- Heterogeneous and conflicting results for depression
- Positive preliminary findings for jet lag and shift work populations
- 16 RCTs provided the strongest evidence base
Limitations
- Many included studies had small sample sizes
- Heterogeneity in lens types, wearing duration, and outcome measures across studies
- Only 2 studies addressed bipolar mania specifically
- Depression evidence was conflicting and inconclusive
- Conference abstracts included which may lack full methodological detail
- Blinding is difficult since participants can see the lens color